한빛사논문
Seung Yeon Koa,b, Sung Eun Wanga,b, Han Kyu Leea,b, Sungsin Joc, Jinil Hand, Seung Hoon Leea,b, Miyeon Choia,b, Hye-Ryeong Joa,b, Jee Young Seoa,b, Sung Jun Junga,b,e,1, and Hyeon Sona,b,f,1
a Graduate School of Biomedical Science and Engineering, Hanyang University, Seongdong-gu, Seoul 04763, Korea; b Hanyang Biomedical Research Institute, Hanyang University, Seongdong-gu, Seoul 04763, Korea; c Hanyang University Hospital for Rheumatic Diseases, Seongdong-gu, Seoul 04763, Korea; d Gencurix, Inc., Guro-gu, Seoul 08394, Korea; e Department of Physiology, College of Medicine, Hanyang University, Seongdong-gu, Seoul 04763, Korea; and f Department of Biochemistry and Molecular Biology, College of Medicine, Hanyang University, Seongdong-gu, Seoul 04763, Korea
1To whom correspondence may be addressed.
Abstract
ajor depressive disorder (MDD) is a devastating disease that arises in a background of environmental risk factors, such as chronic stress, that produce reactive oxygen species (ROS) in the brain. The chronic stress-induced ROS production involves Ca2+ signals; however, the mechanism is poorly understood. Transient receptor potential melastatin type 2 (TRPM2) is a Ca2+-permeable cation channel that is highly expressed in the brain. Here we show that in animal models of chronic unpredictable stress (CUS), deletion of TRPM2 (Trpm2-/-) produces antidepressant-like behaviors in mice. This phenotype correlates with reduced ROS, ROS-induced calpain activation, and enhanced phosphorylation of two Cdk5 targets including synapsin 1 and histone deacetylase 5 that are linked to synaptic function and gene expression, respectively. Moreover, TRPM2 mRNA expression is increased in hippocampal tissue samples from patients with MDD. Our findings suggest that TRPM2 is a key agent in stress-induced depression and a possible target for treating depression.
TRPM2 | depression | ROS | Cdk5 | neurogenesis
논문정보
관련 링크
연구자 키워드
연구자 ID
관련분야 연구자보기
소속기관 논문보기
관련분야 논문보기
해당논문 저자보기